William P. Kane Jr

Insider Reports History

Location
New Haven, CT
Signature
/s/ Marc Panoff, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William P. Kane Jr:

Company Role Class Num Shares Value Price $ Report Date Ownership
Karuna Therapeutics, Inc. Chief Commercial Officer Common Stock 0 $0 $330.00 18 Mar 2024 Direct
Karuna Therapeutics, Inc. Chief Commercial Officer Restricted Stock Units 0 $0 $330.00 18 Mar 2024 Direct
BioXcel Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 40,000 16 Aug 2021 Direct
LB PHARMACEUTICALS INC Director Stock Option (Right to Buy) 22,449 10 Sep 2025 Direct
Karuna Therapeutics, Inc. Chief Commercial Officer Option (right to buy) 0 18 Mar 2024 Direct

Insider Reports Filed by William P. Kane Jr

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000141588925024450-kane-william-p-jr-2025-09-10 LB PHARMACEUTICALS INC 10 Sep 2025 1 $0 4 Director 12 Sep 2025, 18:25
/report/000141588925024181-kane-william-p-jr-2025-09-10 LB PHARMACEUTICALS INC 10 Sep 2025 0 $0 3 Director 10 Sep 2025, 19:24
/report/000114036124013927-kane-william-p-jr-2024-03-18 Karuna Therapeutics, Inc. 18 Mar 2024 4 -$12,091,035 4 Chief Commercial Officer 18 Mar 2024, 16:30
/report/000095017024015972-kane-william-p-jr-2024-02-13 Karuna Therapeutics, Inc. 13 Feb 2024 1 $0 4 Chief Commercial Officer 15 Feb 2024, 16:53
/report/000095017023073878-kane-william-p-jr-2023-12-28 Karuna Therapeutics, Inc. 28 Dec 2023 1 -$1,210,796 4 Chief Commercial Officer 29 Dec 2023, 16:43
/report/000089924323004228-kane-william-p-jr-2023-02-06 Karuna Therapeutics, Inc. 06 Feb 2023 2 $0 4 Chief Commercial Officer 07 Feb 2023, 17:16
/report/000089924323004225-kane-william-p-jr-2023-02-06 Karuna Therapeutics, Inc. 06 Feb 2023 0 $0 3 Chief Commercial Officer 07 Feb 2023, 17:14
BTAI BioXcel Therapeutics, Inc. 16 Aug 2021 1 $0 4 Chief Commercial Officer 18 Aug 2021, 17:25